The largest database of trusted experimental protocols

4 protocols using pe cy7 conjugated anti cd8

1

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with PE-conjugated anti-PD-L1, PerCp-conjugated anti-7-AAD, APC-Cy7-conjugated anti-CD3, PE-Cy7-conjugated anti-CD8, APC-conjugated anti-IFN-γ, and FITC-conjugated anti-granzyme B antibodies (BioLegend, USA). Dead cells were stained using 7-AAD. Among them, IFN-γ and granzyme B were used for intracellular staining as follows: cells were first fixed with 2% paraformaldehyde and permeabilized with 0.1% saponin in phosphate buffered saline (PBS) buffer. Next, cells were incubated in the dark for 15 min on ice with antibodies labeled with fluorochrome. For surface assessment, cells were incubated with fluorochrome-labeled antibodies directly. The cell phenotype was determined using cytofluorimetric analysis by flow cytometer (BD FACSCanto II, USA).
+ Open protocol
+ Expand
2

Murine Spleen Lymphocyte Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens of the control group or LPS-challenged apoM+/+ and apoM−/− mice were harvested aseptically and filtered through cell strainers to produce a single-cell suspension. After lysis of red blood cells, the spleen suspensions were washed three times with PBS and adjusted to a concentration of 1.0 × 107/mL. To detect the changes in lymphocyte subgroups, the prepared splenocytes (1.0 × 107/mL, 100 μL) were incubated with 0.5 μL each of fluorescently labeled antibodies for 30 minutes at 4°C protected from light and washed three times with PBS before analysis. Fluorescently labeled antibodies included FITC-conjugated anti-CD3, PE-Cy5 conjugated anti-CD4, and PE-Cy7 conjugated anti-CD8 (BioLegend, San Diego, CA). The stained cells were then analyzed by flow cytometry immediately (FC500, Beckman, USA).
+ Open protocol
+ Expand
3

Cytokine Production in Activated T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DCs were stimulated with HIV‐1 Cap‐RNA58, R848 or a combination, for 48 h and subsequently cocultured with allogeneic PBLs in IMDM complete, using a 1:8 ratio. As a positive control, T cells were stimulated with anti‐CD3 (1:10,000; Sanquin) and anti‐CD28 (1 μg/ml; Sanquin). After 3 days, IL‐2 was added to the cocultures. After 6 days, cells were restimulated using PMA (10 ng/ml; Sigma) and ionomycin (1 mg/ml; Sigma) for 6 h, and brefeldin A (10 μg/ml; Sigma) for the final 4 h, followed by fixation and permeabilization using the fixation/permeabilization solution kit (BD Biosciences) according to manufacturer's instructions. Cells were then stained using APC‐Cy7‐conjugated anti‐CD3 (1:100, 300317; Biolegend), PE‐Cy7‐conjugated anti‐CD8 (1:100, 344711; Biolegend), FITC‐conjugated anti‐IFNγ (1:5, 340449; BD Biosciences), PE‐conjugated anti‐Perforin (1:10, 12‐9994‐42; Thermo Fisher) and AF700‐conjugated anti‐Granzyme B (1:200, 560213; BD Biosciences) and flow cytometry was performed using FACS Canto II (BD Biosciences) and analyzed with FlowJo software v10.7.
+ Open protocol
+ Expand
4

SARS-CoV-2 Spike Protein T-Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Overnight-rested PBMCs were stimulated with SARS-CoV-2 overlapping peptide pools against SARS-CoV-2 spike protein (PepTivator, Miltenyi Biotec) at a final concentration of 1 μg ml -1 for 1 h in the presence of 1 μg ml -1 monoclonal antibodies CD28 and CD49d, and then for an additional 5 h with GolgiPlug and GolgiStop (BD Biosciences). Dead cells were labelled using Fixable Viability eFluor 780 dye (Thermo Fisher Scientific). Surface markers were stained using BV786-conjugated anti-CD3 (BD Biosciences, 565491; diluted 1:100), BUV486-conjugated anti-CD4 (BD Biosciences, 612937; 1:50), PE-Cy7-conjugated anti-CD8 (BioLegend, 301012; 1:100), APC-Cy7-conjugated anti-CD14 (BioLegend, 301820; 1:100), APC-Cy7-conjugated anti-CD56 (BioLegend, 362512; 1:100) and APC-Cy7-conjugated anti-CD19 (BioLegend, 302218; 1:100). Cells were then washed, fixed with Cytofix/Cytoperm (BD Biosciences) and stained with PE-conjugated anti-IFNγ (BioLegend). Negative controls without peptide stimulation were run for each sample. All results were acquired on a BD LSRFortessa (BD Biosciences) flow cytometer using the BD FACSDIVA v.8.01 software and analysed using FlowJo v.10.6.1 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!